Product NDC: | 0185-1047 |
Proprietary Name: | Quinidine Sulfate |
Non Proprietary Name: | Quinidine Sulfate |
Active Ingredient(s): | 300 mg/1 & nbsp; Quinidine Sulfate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0185-1047 |
Labeler Name: | Eon Labs, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA088072 |
Marketing Category: | ANDA |
Start Marketing Date: | 19830926 |
Package NDC: | 0185-1047-01 |
Package Description: | 100 TABLET in 1 BOTTLE (0185-1047-01) |
NDC Code | 0185-1047-01 |
Proprietary Name | Quinidine Sulfate |
Package Description | 100 TABLET in 1 BOTTLE (0185-1047-01) |
Product NDC | 0185-1047 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Quinidine Sulfate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19830926 |
Marketing Category Name | ANDA |
Labeler Name | Eon Labs, Inc. |
Substance Name | QUINIDINE SULFATE |
Strength Number | 300 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA] |